Enovis Corp
ENOV
Market Cap$2.8B
Close$
$-7.89
115% downside
Current Fair Value
115% downsideOvervalued by 115% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.80 Billion |
|---|---|
| Enterprise Value | $4.07 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.5 |
| Beta | 1.13 |
| Outstanding Shares | 54,850,906 |
| Avg 30 Day Volume | 618,892 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -34.2 |
|---|---|
| PEG | -16.41 |
| Price to Sales | 1.59 |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | 2.24 |
| Enterprise Value to EBIT | -84.61 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...